Home › Prostate Cancer › Pennsylvania › Erie
Prostate Cancer clinical trials in Erie, PA
5 studies for Prostate Cancer are looking for participants at sites in and around Erie (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
RecruitingPhase 3
- Saint Vincent Hospital, Erie
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RecruitingPhase 2
- UPMC Hillman Cancer Center Erie, Erie
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
RecruitingPhase 3
- UPMC Hillman Cancer Center Erie, Erie
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
RecruitingPhase 3
- UPMC Hillman Cancer Center Erie, Erie
Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment
RecruitingPhase 3
- Saint Vincent Hospital, Erie
About Prostate Cancer
Prostate cancer is one of the most common types of cancer among American men. The risk goes up as men age. Learn about symptoms, tests, and treatment.
More about Prostate Cancer on MedlinePlus
Prostate Cancer trials in other cities
- New York City, NY103 studies
- Houston, TX76 studies
- Los Angeles, CA61 studies
- Boston, MA59 studies
- St. Louis, MO46 studies
- Chicago, IL45 studies
- San Francisco, CA45 studies
- Philadelphia, PA44 studies
- Baltimore, MD43 studies
- Nashville, TN42 studies
- Seattle, WA42 studies
- Washington, DC38 studies
Other studies in Erie
- Macular Degeneration10 studies
- Head and Neck Squamous Cell Carcinoma6 studies
- Non-Small Cell Lung Cancer5 studies
- Oral Cancer5 studies
- Geographic Atrophy5 studies
- Lung Cancer4 studies
- Laryngeal Cancer4 studies
- Kidney Cancer (Renal Cell Carcinoma)4 studies
- Endometrial Cancer3 studies
- Amblyopia3 studies
- Breast Cancer3 studies
- Hypopharyngeal Cancer3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.